Neurobiological mechanisms of olfactory dysfunction: a ten-year bibliometric and visualization analysis - Scorecard - MDSpire

Neurobiological mechanisms of olfactory dysfunction: a ten-year bibliometric and visualization analysis

  • By

  • Yuxin Zhu

  • Yutian Chen

  • Genki Izumoji

  • Siying Qu

  • Donghai Wu

  • Huiqin Chu

  • Yixiang Wang

  • Haiju Sun

  • Xiaoyu Li

  • May 13, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Neurobiological Foundations of Olfactory Dysfunction: A Decadal Bibliometric and Visualization Study

At a Glance

CategoryDetail
Condition
Key MechanismsInflammatory cytokines, dysregulation of olfactory receptors, neuroregenerative impairment linked to pathophysiology.
Target Population
Care Setting

Key Highlights

  • emerging_links

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • p
    • h
    • a
    • r
    • m
    • a
    • c
    • o
    • l
    • o
    • g
    • i
    • c
    • a
    • l
    • a
    • g
    • e
    • n
    • t
    • s
    • a
    • n
    • d
    • n
    • o
    • n
    • -
    • p
    • h
    • a
    • r
    • m
    • a
    • c
    • o
    • l
    • o
    • g
    • i
    • c
    • a
    • l
    • t
    • h
    • e
    • r
    • a
    • p
    • i
    • e
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with olfactory dysfunction related to neurodegenerative diseases and COVID-19.

        Interventional trials are exploring various treatment modalities including pharmacological and non-pharmacological approaches.

        Clinical Best Practices

        • examples

        Related Resources & Content

        Original Source(s)

        Neurobiological mechanisms of olfactory dysfunction: a ten-year bibliometric and visualization analysis

        • by Yuxin Zhu, Yutian Chen, Genki Izumoji, Siying Qu, Donghai Wu, Huiqin Chu, Yixiang Wang, Haiju Sun, Xiaoyu Li

        • May 13, 2026

        Related Content

        Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

        This Week’s CGT News: Novo’s Parkinson’s Pivot

        Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

        • May 18, 2026

        • 7 min
        The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model